Table 2.
Clinical characteristics of the association between atherosclerotic and metabolic factors, serum testosterone level, and questionnaire scores.
| Measured/Age standard baPWV (Mean ± SE) |
Ptrend | |||||
|---|---|---|---|---|---|---|
| 0.80–1.00 (0.94 ± 0.01) |
1.00–1.07 (1.03 ± 0.00) |
1.08–1.17 (1.13 ± 0.00) |
1.18–1.27 (1.23 ± 0.00) |
1.28–1.86 (1.41 ± 0.01) |
||
| Case | 61 | 61 | 60 | 61 | 60 | – |
| Abdominal circumference (cm) | 87.3 ± 1.2 | 87.3 ± 0.9 | 87.4 ± 1.4 | 88.9 ± 1.2 | 88.9 ± 1.2 | NS |
| Triglyceride (mg/dL) | 105.0 ± 8.7 | 120.0 ± 9.0 | 137.6 ± 14.3 | 136.2 ± 12.0 | 146.0 ± 15.5 | 0.010 |
| FBS (mg/dL) | 89.8 ± 1.3 | 91.0 ± 1.6 | 95.0 ± 2.6 | 99.0 ± 2.8 | 98.8 ± 3.0 | 0.001 |
| Testosterone (ng/mL) | 5.4 ± 0.3 | 5.5 ± 0.2 | 5.6 ± 0.3 | 5.0 ± 0.2 | 5.0 ± 0.3 | 0.017 |
| SHIM | 10.5 ± 0.8 | 10.7 ± 0.7 | 10.3 ± 0.8 | 10.4 ± 0.8 | 10.4 ± 0.8 | NS |
| EHS | 2.6 ± 0.1 | 2.4 ± 0.1 | 2.2 ± 0.1 | 2.0 ± 0.2 | 2.2 ± 0.1 | 0.012 |
| IPSS | 7.2 ± 0.9 | 6.9 ± 0.8 | 7.5 ± 0.8 | 8.2 ± 0.9 | 8.9 ± 0.9 | 0.036 |
| QOL index | 2.4 ± 0.2 | 2.3 ± 0.2 | 2.5 ± 0.2 | 2.6 ± 0.2 | 3.0 ± 0.2 | 0.016 |
| AMS | 35.8 ± 1.3 | 38.7 ± 1.6 | 39.6 ± 1.5 | 36.4 ± 1.3 | 41.3 ± 1.6 | NS |
AMS, Aging Male Symptoms rating scale; baPWV, brachial-ankle pulse wave velocity; EHS, Erection Hardness Score; FBS, fasting blood sugar; IPSS, International Prostate Symptom Score; NS, not significant; QOL, quality of life; SHIM, Sexual Health Inventory for Men.